跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
METSUNIX 50 MG/1.000 MG COMPRIMIDOS DE LIBERACION MODIFICADA - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
METSUNIX 50 MG/1.000 MG COMPRIMIDOS DE LIBERACION MODIFICADA
Approved
STANDARD
METSUNIX 50 MG/1.000 MG COMPRIMIDOS DE LIBERACION MODIFICADA
Adamed Laboratorios S.L.U.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Mar 31, 2022
Approval ID
780e3d0fe9ed7934
Company
Adamed Laboratorios S.L.U.
Type
Standard
Approval Details
Approval Id
780e3d0fe9ed7934
Drug Cima Aemps Name
METSUNIX 50 MG/1.000 MG COMPRIMIDOS DE LIBERACION MODIFICADA
Register Number
86709
Holder Company Name
Adamed Laboratorios S.L.U.
Marketing Company Name
Adamed Laboratorios S.L.U.
Authorization Date
2022-03-31
Dosage Form
COMPRIMIDO DE LIBERACIÓN MODIFICADA
Dose
50 mg/1.000 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
Yes
Company Name
Adamed Laboratorios S.L.U.
Active Ingredients
SITAGLIPTINA HIDROCLORURO MONOHIDRATO
56,69 mg
METFORMINA HIDROCLORURO
1.000 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Mar 31, 2022
Approval ID
780e3d0fe9ed7934
Type
Standard
Back to CIMA-AEMPS Approvals